Health Care · Pharmaceutical Preparations · NYSE · CIK 1827635 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $104.63Day −2.90%Mkt cap $4.7BOff 52W high −20.3%Vol (1Y) 107.3%
Daily closing price, split-adjusted to the current basis; 0.4y shown of 112 bars on file. Sampled to 112 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest9.4% of sh out |
| Days to cover7.0d |
| Top-10 13F concentration66.2% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$70.0M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
No return windows available for MANE.
| Ann. volatility (1Y)107.3% |
| Ann. volatility (3Y)107.3% |
| Sharpe (1Y)2.64 |
| Sharpe (3Y)2.64 |
| Max drawdown (1Y)−20.8% |
| Max drawdown (3Y)−20.8% |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4.2M | $263M | 11.16% | new |
| SR One Capital Management, LP | 2.4M | $152M | 6.43% | new |
| CITADEL ADVISORS LLC | 1.8M | $115M | 4.89% | new |
| FMR LLC | 1.8M | $113M | 4.80% | new |
| VIKING GLOBAL INVESTORS LP | 1.7M | $107M | 4.53% | new |
| Siren, L.L.C. | 1.5M | $95M | 4.03% | new |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.1M | $69M | 2.95% | new |
| Aberdeen Group plc | 1.1M | $67M | 2.82% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-12 | −$1.32 | — | — | — |
| 2025-03-31 | — | −$19.79 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 43d) — not company-confirmed.
